Intra-arterial thrombolysis for basilar artery thrombosis: Trial it

Stroke

Volumn 38, Issue 2 PART 2, 2007, Pages 704-706

  Powers, William J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute stroke; Brain stem stroke; Thrombolysis; Thrombolytic Rx

Indexed keywords

HEPARIN; UROKINASE; WARFARIN;

BASILAR ARTERY; BASILAR ARTERY THROMBOSIS; BLEEDING; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; BASILAR ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INTRACRANIAL THROMBOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOLYTIC THERAPY;

EID: 33846632841     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254128.05122.a2     Document Type: Conference Paper

References (26)

1. Kubik CS, Adams RD. Occlusion of the basilar artery: a clinical and pathological study. Brain. 1946;69:73-121.
2. Archer CR, Horenstein S. Basilar artery occlusion: clinical and pathological correlation. Stroke. 1977;8:383-390.
3. Labauge R, Pages M, Marty-Double C, Blard JM, Boukobza M, Salvaing P. Occlusion of the basilar artery: a review with 17 personal cases. Rev Neurol (Paris). 1981;137:545-571. [Abstract in English].
4. Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR. 1983;4:401-404.
5. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006;37:922-928.
6. Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, Wilson MC, Richardson WS. Users' guide to the medical literature. XXV. Evidence-based medicine: Principles for applying the users' guide to patient care. JAMA. 2000;284:1290-1296.
7. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA. Results of a multicentre, randomized controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005;20:12-17.
8. Harwood R. Diabetic acidosis: results of treatment in 67 consecutive cases. N Eng J Med. 1951;245:1-9.
9. Abbott JD, Jones DM, Painter MJ, Young SEJ. The epidemiology of meningococcal infections in England and Wales, 1912-1983. J Infect. 1985;11:241-257.
10. McDowell FH, Potes J, Groch S. The natural history of internal carotid and vertebral basilar artery occlusion. Neurology. 1961;11:153-157.
11. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusion. Stroke. 1988;19:1216-1222.
12. Caplan LR. Occlusion of the vertebral or basilar artery: follow up analysis of some patients with benign outcome. Stroke. 1979;10:277-282.
13. Fields WS, Ratinov G, Weibel J, Campos RJ. Survival following basilar artery occlusion. Arch Neurol. 1966;15:463-471.
14. Kim HY, Chung CS, Moon SY, Lee KH, Han SH. Complete nonvisylaization of the basilar artery on MRF angiography in patients with vertebrobasilar ischemic stroke: favorable outcome factors. Cerebrovasc Dis. 2004;18:269-276.
15. Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry. 2005;76:1238-1241.
16. Devuyst G, Bogousslavsky J, Meuli M, Moncayo J, de Freitas G, van Melle G. Stroke or transient ischemic attacks with basilar artery stenosis or occlusion. Arch Neurol. 2002;59:567-573.
17. Voetsch B, DeWitt LD, Pessin MS, Caplan LR. Basilar artery occlusive disease in the New England Medical Center posterior circulation registry. Arch Neurol. 2004;61:496-504.
18. Ezaki Y, Tsutsumi K, Onizuka M, Kawakubo J, Yagi N, Shibayama A, Toba T, Koga H, Miyazaki H. Retrospective analysis of neurological outcomes after intra-arterial thrombolysis in basilar artery occlusion. Surg Neurol. 2003;60:423-430.
19. Arnold M, Nedeltchev K, Schroth G, Baumgartner RW, Remonda L, Loher TJ, Stepper F, Sturznegger M, Schuknecht B, Mattle HP. Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry. 2004;75:857-862.
20. Schwarz S, Egelhof T, Schwab S, Hacke W. Basilar artery embolism: clinical syndrome and neuroradiologic patterns in patients without permanent occlusion of the basilar artery. Neurology. 1997;49:1346-1352.
21. Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Alvarez-Sabin J. Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. Thromb Haemost. 2004;91:1146-1151.
22. Huber K. Plasminogen activator inhibitor type-1 (Part one): basic mechanisms, regulation and role for thromboembolic disease. J Thromb Thrombolys. 2001;11:183-193.
23. Cross DT, Derdeyn CP, Moran CJ. Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activator. AJNR. 2001;22:521-525.
24. Garrard CL, Manord JD, Ballinger BA, Kateiva JE, Sternbergh WC III, Bowen JC, Money SR. Cost savings associated with the nonroutine use of carotid angiography. Am J Surg. 1997;174:650-654.
25. Pronovost PJ, Needham DM, Waters H, Birkmeyer CM, Calinawan JR, Borkmeyer JD, Dorman T. Intensive care unit physician staffing: Finincail modeling of the Leapfrog standard. Crit Care Med. 2006;34 (Suppl):S18-S24.
26. http://medcareforum.com/wp-content/projections.jpg. Accessed May 14, 2006.